Literature DB >> 10882391

Role of A(2A)-adenosine receptor activation for ATP-mediated coronary vasodilation in guinea-pig isolated heart.

K S Erga1, C N Seubert, H X Liang, L Wu, J C Shryock, L Belardinelli.   

Abstract

1. Adenosine-5'-triphosphate (ATP) and adenosine are potent coronary vasodilators. ATP is rapidly converted to adenosine by ectonucleotidases. We examined whether coronary vasodilation caused by exogenous ATP is mediated by P(2) receptor activation or by A(2A)-adenosine receptor activation. 2. Effects of interventions on coronary conductance were determined by measuring coronary perfusion pressure in guinea-pig isolated hearts perfused at a constant flow of 10 ml min(-1). 3. ATP and adenosine both caused sustained, concentration-dependent increases of coronary conductance. Maximal responses to both agonists were equivalent. The values of pD(2) (+/-s.e.mean) for ATP and adenosine were 6.68+/-0.04 and 7.06+/-0.05, respectively. Adenosine was significantly more potent than ATP (P<0. 0001, n=10). 4. The values of pIC(50) for the selective A(2A)-adenosine receptor antagonist SCH58261 to antagonize equivalent responses to ATP and adenosine were 8.28+/-0.08 and 8.28+/-0.06 (P=0.99, n=6), respectively. 5. The non-selective adenosine receptor antagonists xanthine amine congener (XAC) and CGS15943 antagonized similarly the equivalent vasodilations caused by ATP (pIC(50) values 7.48+/-0.04 and 7.45+/-0.06, respectively) and adenosine (pIC(50) values 7. 37+/-0.13 and 7.56+/-0.11). 6. In contrast to ATP and adenosine, the two P(2) agonists 2-methylthio-ATP and uridine-5'-triphosphate failed to cause stable increases of coronary conductance, caused desensitization of vasodilator responses, and were not antagonized by SCH 58261, 8-parasulphophenyltheophylline, or XAC. 7. Glibenclamide attenuated coronary vasodilations caused by ATP and adenosine by 88 and 89%, respectively, but failed to attenuate those caused by 2-methylthio-ATP. 8. These results strongly suggest that sustained, submaximal coronary vasodilation caused by exogenous ATP is entirely mediated by adenosine acting upon A(2A)-adenosine receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882391      PMCID: PMC1572153          DOI: 10.1038/sj.bjp.0703386

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  54 in total

Review 1.  Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology.

Authors:  J C Shryock; L Belardinelli
Journal:  Am J Cardiol       Date:  1997-06-19       Impact factor: 2.778

2.  Cloning of the rat P2u receptor and its potential role in coronary vasodilation.

Authors:  S Gödecke; U K Decking; A Gödecke; J Schrader
Journal:  Am J Physiol       Date:  1996-02

3.  Kinetics of extracellular ATP hydrolysis by microvascular endothelial cells from rat heart.

Authors:  P Meghji; J D Pearson; L L Slakey
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

4.  Involvement of ATP in the non-adrenergic non-cholinergic inhibitory neurotransmission of lamb isolated coronary small arteries.

Authors:  U Simonsen; A García-Sacristán; D Prieto
Journal:  Br J Pharmacol       Date:  1997-02       Impact factor: 8.739

5.  Quantitative relation between interstitial adenosine concentration and coronary blood flow.

Authors:  D W Stepp; R Van Bibber; K Kroll; E O Feigl
Journal:  Circ Res       Date:  1996-09       Impact factor: 17.367

6.  Intracoronary administration of adenosine triphosphate increases myocardial adenosine levels and coronary blood flow in man.

Authors:  S Nanto; M Kitakaze; Y Takano; M Hori; S Nagata
Journal:  Jpn Circ J       Date:  1997-10

7.  The A2A adenosine receptor mediates coronary vasodilation.

Authors:  L Belardinelli; J C Shryock; S Snowdy; Y Zhang; A Monopoli; G Lozza; E Ongini; R A Olsson; D M Dennis
Journal:  J Pharmacol Exp Ther       Date:  1998-03       Impact factor: 4.030

8.  ATP: the red blood cell link to NO and local control of the pulmonary circulation.

Authors:  R S Sprague; M L Ellsworth; A H Stephenson; A J Lonigro
Journal:  Am J Physiol       Date:  1996-12

9.  Binding of the novel nonxanthine A2A adenosine receptor antagonist [3H]SCH58261 to coronary artery membranes.

Authors:  L Belardinelli; J C Shryock; J Ruble; A Monopoli; S Dionisotti; E Ongini; D M Dennis; S P Baker
Journal:  Circ Res       Date:  1996-12       Impact factor: 17.367

10.  Pharmacological analysis of responses to ATP in the isolated and perfused canine coronary artery.

Authors:  T Matsumoto; T Nakane; S Chiba
Journal:  Eur J Pharmacol       Date:  1997-09-10       Impact factor: 4.432

View more
  9 in total

1.  Functional contribution of P2Y1 receptors to the control of coronary blood flow.

Authors:  Shawn B Bender; Zachary C Berwick; M Harold Laughlin; Johnathan D Tune
Journal:  J Appl Physiol (1985)       Date:  2011-09-22

2.  Augmentation of Muscle Blood Flow by Ultrasound Cavitation Is Mediated by ATP and Purinergic Signaling.

Authors:  J Todd Belcik; Brian P Davidson; Aris Xie; Melinda D Wu; Mrinal Yadava; Yue Qi; Sherry Liang; Chae Ryung Chon; Azzdine Y Ammi; Joshua Field; Leanne Harmann; William M Chilian; Joel Linden; Jonathan R Lindner
Journal:  Circulation       Date:  2017-02-07       Impact factor: 29.690

3.  ATP-loaded liposomes effectively protect mechanical functions of the myocardium from global ischemia in an isolated rat heart model.

Authors:  D D Verma; T S Levchenko; E A Bernstein; V P Torchilin
Journal:  J Control Release       Date:  2005-10-17       Impact factor: 9.776

Review 4.  Pleiotropic effects of clopidogrel.

Authors:  Dawn S Kuszynski; D Adam Lauver
Journal:  Purinergic Signal       Date:  2022-06-09       Impact factor: 3.950

5.  Ecto-5'-nucleotidase, CD73, is an endothelium-derived hyperpolarizing factor synthase.

Authors:  Masanori Ohta; Kazuyoshi Toyama; David D Gutterman; William B Campbell; Vincent Lemaître; Ryutaro Teraoka; Hiroto Miura
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

6.  Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases.

Authors:  S A Lévesque; E G Lavoie; J Lecka; F Bigonnesse; J Sévigny
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

7.  Coronary artery reperfusion: The ADP receptor P2Y(1) mediates early reactive hyperemia in vivo in pigs.

Authors:  Goran K Olivecrona; Matthias Gotberg; Jan Harnek; Lingwei Wang; Kenneth A Jacobson; David Erlinge
Journal:  Purinergic Signal       Date:  2004-12       Impact factor: 3.765

8.  Insulin induces the release of vasodilator compounds from platelets by a nitric oxide-G kinase-VAMP-3-dependent pathway.

Authors:  Voahanginirina Randriamboavonjy; Jürgen Schrader; Rudi Busse; Ingrid Fleming
Journal:  J Exp Med       Date:  2004-01-26       Impact factor: 14.307

9.  ATP-induced cardioprotection against myocardial ischemia/reperfusion injury is mediated through the RISK pathway.

Authors:  Zhe-Xun Lian; Fang Wang; Jun-Hua Fu; Zuo-Yuan Chen; Hui Xin; Ru-Yong Yao
Journal:  Exp Ther Med       Date:  2016-08-02       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.